Skip to content

Under Pressure II: evaluation of a culture sensitive educational programme for Afro Surinamese and Ghanaian patients with hypertension.

Under Pressure II: evaluation of a culture sensitive educational programme for Afro Surinamese and Ghanaian patients with hypertension. - Under Pressure II (UPII)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33054
Enrollment
120
Registered
2009-08-25
Start date
2009-07-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure Hypertension

Interventions

Patients in the intervention group will receive three educational counselling sessions according to the protocol of culturally sensitive hypertension education with an interval of three months. Pati

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: African-Surinamese of Ghanaian (self-identification) Aged 20 or more Diagnosis hypertension Uncontrolled blood pressure (>140/90)

Exclusion criteria

Exclusion criteria: Diabetes Mellitus type I+II Participation in other trials for cardiovascular disease If GP decides a patient is not appropriate for participation (e.g. co-morbidity)

Design outcomes

Primary

MeasureTime frame
Baseline systolic BP minus systolic BP after 8 months (BP will be measured according to protocol: Average of two electronic BP measurements which are conducted with an interval of 15 minutes in sitting patients)

Secondary

MeasureTime frame
Changes after eight months with regard to the degree of medication compliance, compliance with life style recommendations, potentially mediating factors for hypertension management (beliefs, motivation, self efficacy) and satisfaction with care. These parameters will be measured through questionnaires

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)